Navigation Links
Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2022
Date:4/12/2017

NEW YORK, April 12, 2017 /PRNewswire/ -- The global influenza vaccines market is anticipated to reach nearly US$ 5 Billion by 2022. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.

Geographically, North America is the largest market for influenza vaccines capturing nearly 50% market share in 2016. Asia is the second largest market for influenza vaccines. Europe is the third largest market for influenza vaccines, followed by Latin America with around XX% share in 2016. Australasia accounted for least share of the influenza vaccines market in 2016.

On the basis of country, United States captures majority of the influenza vaccines market share. Japan is the second leading market for influenza vaccines with around XX% share. China and India are the third and fourth leading market for influenza vaccines with XX% and XX% market share respectively in 2016. Brazil, Germany, France, UK, Italy, Spain and South Korea are the other leading market for influenza vaccines.

In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. Afluria/Fluvax and FluMist/Fluenz stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.

This is the 3rd edition report on influenza vaccines market by iGATE Research. The report titled "Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2022" provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 216 Page report contains 137 Figures and 12 Tables to present a clear picture of the influenza vaccines market landscape.

The Influenza Vaccines Market have been analyzed from 5 viewpoints:
1. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2022)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2022)
3. Global - Influenza Vaccines Brand Sales and Forecast to 2022
4. Global Influenza Vaccines Market - Major Deals
5. Global Influenza Vaccines Market - Driving Factors and Challenges

Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region
1. North America
2. Latin America
3. Europe
4. Asia
5. Australasia

Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (25 Countries Covered)
1. United States
2. Canada
3. Brazil
4. Mexico
5. Germany
6. France
7. Italy
8. Spain
9. United Kingdom
10. Netherlands
11. Ireland
12. Denmark
13. Luxembourg
14. Sweden
15. Australia
16. New Zealand
17. Japan
18. China
19. India
20. South Korea
21. Singapore
22. Hong Kong
23. Malaysia
24. Thailand
25. Indonesia

Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed
1. Fluarix/FluLaval
2. Fluzone
3. Fluvirin/Flucelvax
4. Influvac
5. Afluria/Fluvax
6. FluMist/Fluenz
7. Flublok

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases

Read the full report: http://www.reportlinker.com/p04822050-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-influenza-vaccines-market-persons-vaccinated-brand-analysis-and-forecast-to-2022-300439098.html


'/>"/>
SOURCE Reportlinker
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global $9.51 Billion Wound Closure Products Market 2016-2022 - Research and Markets
2. Global Hot and Cold Therapy Packs Market Report 2017: Forecast to 2024 with Market Size, Market Share, Application Analysis & Regional Outlook - Research and Markets
3. Global Ibuprofen / Pseudoephedrine Sales, Price Analysis, & Sales Forecast Report 2017-2021 - Research and Markets
4. Roche launches new global Certified Provider Program for Target Enrichment in Genomic Sequencing
5. Research and Markets - Global Radiosurgery and Radiotherapy Robotics Market to Grow at a CAGR of 6.4%, 2017-2021 with Accuray, Brainlab, Elekta & Varian Medical Systems Dominating
6. Global Mycoplasma Diagnostics Market to Reach US$1.35 Billion by 2024: Rising Awareness About Latest Advancements in Diagnostics to Enable Growth, Says TMR
7. Global Pharmaceutical Contract Packaging Market to Grow at a CAGR of 14.5% by 2021 - High Demand for Pharmaceutical Contract Packaging in Emerging Economies - Research and Markets
8. Research and Markets - Global Respiratory Diagnostic and Monitoring Device Market, 2022: Key Players are General Electric, Masimo, Hamilton Medical, Koninklijke Philips & Medtronic
9. Global Advanced Remote Patient Monitoring Systems Markets 2012-2021 - Research and Markets
10. Global Emerging Cancer Diagnostics Market Analysis & Forecast 2017-2023: Market Is Expected To Grow At A CAGR Of 13.45% and Reach $6.34 Billion - Research and Markets
11. Research and Markets - Global $30.2 Billion Respiratory Complications Therapeutics Market to 2022: Pfizer is Expected to Maintain its Position as Market Leader
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... 11, 2017 Zymo Research Corp., also known as ,The Epigenetics ... biological aging in a precise manner using the myDNAge ™ test. ... a professor of human genetics and biostatistics at the David Geffen ... Health , Zymo Research,s proprietary DNAge ™ technology is used to ... ...
(Date:7/11/2017)... founder of Echenberg Institute, is announcing a new safe and effective at-home ... and other painful pelvic pain conditions such as pelvic floor dysfunction, vulvodynia, ... ... ... start-up company, VuVatech LLC, fills a void in the women,s wellness market ...
(Date:7/10/2017)... , July 10, 2017  BDI Group ... and patient support services organization serving specialty pharmacies, ... the launch of four significant, value-added member programs ... insights, better manage reimbursement and improve access and ... factor therapies. ...
Breaking Medicine Technology:
(Date:7/21/2017)... Pass, OR (PRWEB) , ... July 21, 2017 ... ... in recent weeks Nature’s Tears® EyeMist®, the signature product of her research center ... country with the world’s largest population and the greatest number of sufferers of ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... with over 80% follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome ... knee-related quality of life a decade after surgery, though activity levels decline over ...
(Date:7/21/2017)... ... 21, 2017 , ... How physicians and athletic trainers assess ... researchers presenting their work at the American Orthopaedic Society for Sports Medicine’s ... the patterns of change in concussion symptom presentation, diagnostic tools used and length ...
(Date:7/20/2017)... ... , ... ChenMed , a leading provider of value-based care for seniors, ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine ... Ambulatory Services for the UVA Health System, brings 30 years of highly relevant experience ...
(Date:7/20/2017)... July 20, 2017 (PRWEB) , ... ... ... Technologies, a global provider of enterprise-grade IT operations analytics and application performance ... of one of world’s largest healthcare services providers. , According to Peter ...
Breaking Medicine News(10 mins):